Case Report
Arterial Stiffness in a Toddler with Neurofibromatosis Type 1 and Refractory Hypertension
Table 1
Clinical, laboratory, and imaging data during follow-up visits.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Central BP was measured by an oscillometric device (SpygmoCor, AtCor Medical). 2Reference values available for children older than 7 yrs.: 5.26 m/sec 95th percentile for 7-year-old girls, 5.06 m/sec 95th percentile for 7-year-old girls. 3eGFR was based on Schwartz formula. 4Renin and aldosterone at rest was measured after night’s rest in the supine position and then active after 1 hour walking in the upright position.5 Antihypertensive drugs doses: valsartan:1.3 mg/kg/day qd; felodipine: 2.5 mg daily qd; amlodipine: 0.5 mg/kg/day qd; furosemide: 1 mg/day bid; atenolol:1 mg/kg/day bid; clonidine: 0.1 mg/day bid. BP: blood pressure; cf-PWV: carotid-femoral pulse wave velocity; MRA: magnetic resonance angiography; CTA: computed tomography angiography; DTPA: 99mTc-diethylenetriaminepentaacetic acid. |